Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis

Clinical trial NCT00468611 · TERMINATED

Trial details

NCT number: NCT00468611
Sponsor: BioMS Technology Corp.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis, Secondary Progressive

Start date: 2007-06-01
Primary completion: 2009-07-01
Enrollment: 510

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.